Fluoride in Dental Caries Prevention and Treatment: Mechanisms, Clinical Evidence, and Public Health Perspectives · Yeh CH, Wang YL, Vo TTT et al.

2. Fluoride-Based Products and Clinical Applications

Over the past several decades, various fluoride-based products have been developed for both professional and personal use in the prevention and management of dental caries. The choice of a particular fluoride modality depends on multiple factors, including patient age, individual caries risk, esthetic considerations, and the level of fluoride exposure in the local environment. Understanding the specific characteristics, mechanisms, and clinical implications of these products is critical for tailoring effective preventive strategies.

2.1. Fluoride Toothpaste

Among all fluoride delivery vehicles, fluoridated toothpaste remains the most accessible and widely used method for caries prevention [5]. Standard formulations for adults typically contain fluoride concentrations ranging from 1000 to 1500 ppm, delivered through compounds such as sodium fluoride (NaF), stannous fluoride (SnF2), or sodium monofluorophosphate (MFP). These formulations effectively promote remineralization and inhibit the demineralization process, contributing significantly to the decline in caries prevalence over recent decades [10]. However, variations in study design and population characteristics make it difficult to attribute the decline solely to fluoride toothpaste, and other public health measures may also have contributed. For children under six years of age, lower fluoride concentrations between 500 and 1000 ppm are recommended to minimize the risk of dental fluorosis, particularly since young children may inadvertently swallow toothpaste during brushing. According to the latest protocol of the American Academy of Pediatric Dentistry, the use of fluoride toothpaste should begin with the eruption of the first primary tooth, with parents or caregivers supervising the amount applied to reduce ingestion risk [11,12]. For adults, restorative dentistry textbooks specify that toothpaste should contain at least 1000 ppm fluoride to ensure caries-preventive efficacy, while other guidelines recommend 1350–1500 ppm as the standard range for optimal protection [5,13,14]. In addition to conventional formulations, high-fluoride toothpastes containing up to 5000 ppm fluoride are available by prescription for adults at elevated caries risk, such as those with xerostomia, orthodontic appliances, or a history of rampant caries [13]. Clinical guidelines emphasize using only a pea-sized amount of toothpaste and supervising brushing in young children to reduce systemic fluoride exposure [11,12]. Nevertheless, adherence to these recommendations in real-world settings remains inconsistent, particularly in low-literacy or resource-limited communities, which may reduce the effectiveness of these preventive strategies. Despite these precautions, twice-daily brushing with fluoridated toothpaste remains a cornerstone of modern caries prevention across all age groups [13], highlighting the importance of proper patient education and compliance in achieving optimal outcomes [14]. Yet, evidence suggests that compliance is strongly influenced by socioeconomic status and health literacy, indicating that toothpaste efficacy in clinical trials may not always translate into community-wide effectiveness. Additional fluoride compounds such as amine fluoride (AmF) and SnF2 should also be acknowledged. Amine fluoride acts more rapidly due to its surfactant properties and strong enamel adhesion [15], whereas MFP requires enzymatic hydrolysis and thus releases fluoride more slowly [16]. Stannous fluoride not only provides fluoride ions but also exerts antimicrobial activity through tin, offering broader protective effects [17]. Importantly, synergistic benefits have been observed when AmF is combined with SnF2, resulting in enhanced antibacterial and anti-demineralization properties [18]. Still, comparative trials evaluating the long-term superiority of these combined formulations over conventional fluoride toothpastes remain limited. Accessibility to fluoridated toothpaste, however, differs substantially across regions worldwide. In most high-income countries, the majority of households have routine access to affordable fluoride toothpaste through retail markets and public health programs, which has contributed to significant reductions in caries prevalence. In contrast, surveys from low- and middle-income countries indicate that availability remains limited, with usage rates below 30% in some parts of sub-Saharan Africa and Southeast Asia due to cost, distribution challenges, and lack of regulatory standards. These disparities emphasize the need for global health initiatives to ensure equitable access to fluoride toothpaste as an essential preventive measure [19,20,21]. These global disparities underscore not only the importance of fluoride toothpaste access but also the need for culturally tailored health promotion programs to improve acceptance and sustained use. Future research may explore combining fluoride with additional remineralizing agents to enhance its preventive efficacy further. Fluoride mouthwashes serve as an adjunctive caries-preventive modality. Common over-the-counter formulations include 0.05% sodium fluoride (~230 ppm F) for daily use and 0.2% NaF (~900 ppm F) for weekly use in school-based programs. These rinses contain similar fluoride compounds to toothpaste, such as NaF, and are particularly beneficial for high-caries-risk patients by sustaining low-level fluoride exposure in the oral environment [22].

2.2. Fluoride Varnishes and Mouthrinses

Fluoride varnishes are professionally applied topical agents designed to deliver high concentrations of fluoride directly to the tooth surface. Typically formulated as 5% sodium fluoride varnish, they contain approximately 22,600 ppm fluoride. These varnishes adhere to enamel, allowing sustained fluoride release over several hours and enhancing remineralization while reducing cariogenic bacterial activity [23]. Nevertheless, reported effectiveness varies across studies, partly due to differences in application protocols, follow-up duration, and patient compliance, which complicates the direct comparison of outcomes. Clinical evidence demonstrates that fluoride varnish applications performed two to four times per year can reduce the incidence of dental caries in permanent teeth by up to 43% [5]. It should be noted, however, that this preventive effect is not uniform across populations, with some trials reporting more modest reductions, highlighting the need for standardized protocols and longer-term evaluation. Varnishes are particularly suitable for young children, including those under six years old, because they are professionally applied and minimize systemic ingestion. Despite this advantage, professional application increases costs and limits accessibility in low-resource settings, raising concerns about equity in preventive care. Additionally, varnishes offer significant benefits for patients with high caries risk, orthodontic appliances, or exposed root surfaces [4]. As fluoride varnish continues to gain recognition as a versatile tool in preventive dentistry, ongoing research is exploring the integration of calcium-phosphate additives to improve efficacy and patient acceptance. Yet, evidence regarding the clinical superiority of such modified varnishes remains preliminary, and further large-scale randomized trials are required before routine adoption. In contrast, fluoride mouthrinses are generally formulated at concentrations of 230 ppm for daily use or 900 ppm for weekly applications. They are effective in reducing caries incidence, particularly in individuals at high risk for dental caries. However, these rinses are generally not recommended for children younger than six years due to the increased risk of ingestion and potential systemic toxicity [3,12]. Moreover, patient adherence to regular rinsing regimens is often suboptimal, which may diminish real-world effectiveness despite strong evidence from controlled studies.

2.3. Fluoride Supplements (Tablets and Drops)

Fluoride supplements, available as tablets or drops, are intended for systemic use in regions lacking adequate community water fluoridation or where natural fluoride levels are insufficient. The prescribed dosage varies based on a child’s age and the fluoride concentration in the local water supply, usually ranging from 0.25 to 1.0 mg per day [12]. When taken during tooth development, systemic fluoride can integrate into hydroxyapatite, enhancing enamel resistance to acid dissolution [3]. Nonetheless, the actual cariostatic benefit of systemic supplementation has been inconsistent across studies, and much of the supporting evidence comes from older trials with methodological limitations. However, careful monitoring is essential to prevent excessive fluoride intake, which increases the risk of dental fluorosis. This concern has fueled ongoing debates regarding the ethical balance between population-level caries prevention and the potential for iatrogenic harm, particularly in young children. Consequently, the use of systemic fluoride supplements has declined in many regions, as topical fluoride modalities offer effective caries prevention with a lower risk of systemic exposure. Moreover, declining prescription rates in high-income countries contrast with continued use in some low- and middle-income regions, reflecting disparities in public health policies and resource availability. Despite their efficacy in specific high-risk populations, the preference has shifted toward topical approaches whenever feasible, underscoring the need for individualized assessments of total fluoride exposure. Future research should focus on refining guidelines for systemic supplementation, incorporating factors such as dietary fluoride intake, regional water fluoridation variability, and genetic susceptibility to fluorosis.

2.4. Silver Diamine Fluoride (SDF)

SDF is a topical agent used for arresting active carious lesions and offers a non-invasive alternative for caries management, particularly in populations with limited access to restorative care [24]. Clinical evidence from systematic reviews and randomized controlled trials supports its high efficacy compared with other topical fluoride treatments, with studies highlighting its significant role in community-based caries management and preventive programs [25,26,27]. However, the magnitude of benefit has varied between studies, and most long-term data are derived from pediatric populations, leaving uncertainty about the durability of the effect in adults. Despite these advantages, one significant limitation of SDF is the black staining that occurs on arrested lesions, which may pose esthetic concerns, especially for anterior teeth. This esthetic concern often limits parental acceptance, and cultural attitudes toward visible staining further influence treatment uptake across different regions. Nonetheless, SDF remains a transformative tool in minimally invasive dentistry, emphasizing the importance of comprehensive patient and parent counseling to manage expectations regarding esthetic outcomes. Ongoing research aims to develop formulations that preserve SDF’s caries-arresting potential while minimizing discoloration [25,26,27]. Yet, current experimental formulations have shown mixed results, and large-scale clinical validation is still lacking. In pediatric dentistry, SDF is strongly recommended, particularly for young or uncooperative children with early childhood caries, due to its proven efficacy and ease of application [25,26,27]. Nevertheless, questions remain about optimal reapplication intervals, cost-effectiveness compared with other preventive strategies, and integration into comprehensive caries management protocols. However, some restorative dentistry and caries textbooks for adults do not recommend routine SDF applications because of the esthetic drawback of black staining and the availability of restorative alternatives [24]. Nevertheless, SDF may be beneficial in adults with high caries risk, root caries, or those who are medically compromised and unable to receive conventional restorative treatments [24]. Future investigations should also explore patient-reported outcomes, long-term cost-effectiveness, and strategies to improve esthetic acceptability while retaining clinical efficacy.

2.5. Comparison of Fluoride Products

Numerous fluoride-based products are available for both professional and personal use, each differing in fluoride concentration, mechanism of action, clinical indications, and potential limitations [1,2,3]. Table 1 provides a comparative overview of these fluoride products, summarizing key aspects to assist clinicians in selecting the most appropriate intervention tailored to individual patient needs, caries risk, and practical considerations. However, head-to-head comparative trials remain scarce, and most data are derived from heterogeneous study designs, which limits the ability to establish clear superiority among products. While topical fluoride applications such as toothpaste and varnishes remain the primary preventive measures [13,25], fluoride gels (neutral or acidulated) also play a role in professional care, with variations in pH designed to balance enamel safety and fluoride uptake [28]. Yet, evidence regarding the clinical advantage of one formulation over another remains inconclusive, suggesting that practitioner preference often outweighs strong comparative data. Products such as MI Paste and MI Paste Plus (GC Tooth Mousse series) provide casein phosphopeptide–amorphous calcium phosphate (CPP-ACP) with or without fluoride, supporting remineralization and offering alternatives for patients with sensitivity or high caries risk [4,29,30,31]. Still, long-term outcomes and cost-effectiveness data for CPP-ACP-based products remain limited, and their role relative to conventional fluoride strategies is not fully established. Additionally, prophylaxis pastes applied after scaling procedures may contain fluoride and contribute to short-term enamel protection [32,33]. Newer modalities like silver diamine fluoride offer promising alternatives for caries arrest, particularly in populations with limited access to conventional restorative care [24,26,27]. However, esthetic concerns, especially staining associated with SDF, require careful consideration [27,34]. Acceptance also varies considerably across cultural and socioeconomic contexts, further complicating the integration of SDF into mainstream practice. Systemic fluoride supplements, while effective, have seen declining use due to the risk of fluorosis and the growing emphasis on topical interventions [9,10]. Nevertheless, debates persist regarding whether systemic supplementation should be re-evaluated in communities with poor access to topical products, highlighting the tension between efficacy, safety, and equity in global caries prevention. Nevertheless, they remain clinically relevant in areas lacking water fluoridation or where the dietary intake of fluoride is insufficient [35]. Ultimately, choosing the optimal fluoride strategy should be guided by evidence-based recommendations, patient preferences, and practical considerations such as cost-effectiveness, availability, and patient compliance. Future research should prioritize comparative effectiveness studies that include patient-reported outcomes, cultural acceptability, and real-world cost–benefit analyses to better inform clinical and public health recommendations.

2.6. Emerging Fluoride Technologies

Beyond traditional fluoride modalities, emerging technologies are being explored to enhance caries prevention and improve patient outcomes. One promising avenue involves the use of nano-hydroxyapatite (nHAp), a biomimetic material that closely resembles the natural mineral composition of tooth enamel. Studies suggest that nHAp can effectively occlude enamel porosities, promote remineralization of early carious lesions, and reduce dentin hypersensitivity [36,37]. However, much of the evidence is derived from short-term or in vitro studies, and the durability of these effects in long-term clinical use remains uncertain. When used alongside fluoride, nHAp may contribute to remineralization, although current evidence indicates that fluoride remains the primary agent for caries prevention [4]. This underscores that nHAp should be viewed as a potential adjunct rather than a replacement, pending stronger comparative clinical data. Another emerging approach involves fluoride-containing bioactive glass formulations. Fluoride-containing bioactive glasses have shown promise in in vitro studies for promoting enamel remineralization, although robust clinical data remain limited, and further research is needed to validate their efficacy compared with established fluoride therapies [3,4]. At present, the lack of randomized controlled trials limits their integration into evidence-based guidelines. Moreover, research has focused on innovative delivery systems, such as sustained-release varnishes and polymeric carriers designed to prolong fluoride availability at the tooth surface [4]. These novel delivery vehicles aim to enhance the substantivity of fluoride and reduce the frequency of applications, which could improve patient compliance and long-term preventive effectiveness. Yet, these delivery systems often involve higher costs and greater manufacturing complexity, which may hinder widespread adoption, particularly in low-resource settings. Other experimental additives, such as silver nanoparticles and zinc oxide nanoparticles, are also under investigation for their antibacterial and cariostatic potential, although robust clinical data remain limited. Additionally, potential cytotoxicity and long-term biocompatibility of nanoparticles remain underexplored, warranting caution before clinical translation. In addition to these novel approaches, restorative materials themselves can act as fluoride reservoirs. Glass ionomer cements (GICs) were among the first restorative materials with inherent fluoride release, providing long-term anticariogenic effects and reducing the risk of secondary caries [38]. Nevertheless, the fluoride release from restorative materials tends to decline over time, and the true magnitude of their anticariogenic benefit in vivo is still debated. Advances in adhesive technology have also led to the development of fluoride-containing bonding agents capable of sustained fluoride release within the hybrid layer, offering added protection against demineralization at restoration margins [39]. Furthermore, fluoride-releasing composite resins are now available, which, although releasing fluoride at lower levels than GICs, still contribute to localized caries prevention around restorations [40]. Further comparative studies are needed to determine whether these materials provide clinically meaningful advantages over conventional composites. While preliminary data for these emerging technologies appear promising, significant challenges remain. These include higher production costs, limited availability, and a lack of robust clinical evidence directly comparing these technologies to well-established fluoride therapies. Future research should prioritize large-scale, well-designed clinical trials to determine whether these newer modalities can achieve comparable or superior outcomes in caries prevention, particularly in high-risk populations. Nonetheless, emerging fluoride technologies hold substantial promise for improving both the efficacy and esthetics of caries prevention, potentially offering alternatives for patients who have concerns about the drawbacks of existing fluoride treatments, such as staining or taste alterations. Ultimately, without rigorous cost-effectiveness analyses and patient-reported outcome studies, the clinical role of these emerging technologies will remain uncertain.